» Articles » PMID: 22158050

MicroRNA-520/373 Family Functions As a Tumor Suppressor in Estrogen Receptor Negative Breast Cancer by Targeting NF-κB and TGF-β Signaling Pathways

Overview
Journal Oncogene
Date 2011 Dec 14
PMID 22158050
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) as modulators of gene expression have been described to display both tumor-promoting and tumor-suppressive functions. Although their role has been studied in different tumor types, little is known about how they regulate nuclear factor κB (NF-κB) signaling in breast cancer. Here, we performed an unbiased whole genome miRNA (miRome) screen to identify novel modulators of NF-κB pathway in breast cancer. The screen identified 13 miRNA families whose members induced consistent effects on NF-κB activity. Among those, the miR-520/373 family inhibited NF-κB signaling through direct targeting of RELA and thus strongly reduced expression and secretion of the pro-inflammatory cytokines interleukin (IL)-6 and IL-8. With a combination of in vitro and in vivo approaches, we propose a metastasis-suppressive role of miR-520/373 family. miR-520c and miR-373 abrogated both in vitro cell invasion and in vivo intravasation of highly invasive MDA-MB-231 cells. However, knockdown of RELA did not affect their metastatic ability. mRNA profiling of MDA-MB-231 cells on overexpression of miR-520/373 members revealed a strong downregulation of transforming growth factor-β (TGF-β) signaling. Mechanistically, the metastasis-suppressive role of miR-520/373 can be attributed to direct suppression of TGFBR2, as the silencing of TGFBR2 phenocopied the effects of miR-520/373 overexpression on suppression of Smad-dependent expression of the metastasis-promoting genes parathyroid hormone-related protein, plasminogen activator inhibitor-1 and angiopoietin-like 4 as well as tumor cell invasion, in vitro and in vivo. A negative correlation between miR-520c and TGFBR2 expression was observed in estrogen receptor negative (ER(-)) breast cancer patients but not in the ER positive (ER(+)) subtype. Remarkably, decreased expression of miR-520c correlated with lymph node metastasis specifically in ER(-) tumors. Taken together, our findings reveal that miR-520/373 family has a tumor-suppressive role in ER(-) breast cancer by acting as a link between the NF-κB and TGF-β pathways and may thus contribute to the interplay of tumor progression, metastasis and inflammation.

Citing Articles

Pan-cancer analysis of the potential of PEA3 subfamily genes as tumor markers.

Guan L, Zeng R, Chen Y, He G, Yao W, Liu Z Sci Rep. 2024; 14(1):31518.

PMID: 39732961 PMC: 11682092. DOI: 10.1038/s41598-024-82973-9.


Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis.

Khan M, Wong G, Zhuang C, Najjar M, Lo H Front Oncol. 2024; 14:1436942.

PMID: 39175471 PMC: 11338853. DOI: 10.3389/fonc.2024.1436942.


Integrated grade-wise profiling analysis reveals potential plasma miR-373-3p as prognostic indicator in Prostate Cancer & its target KPNA2.

Khan M, Sharma V, Serajuddin M, Kirabo A Noncoding RNA Res. 2024; 9(3):954-963.

PMID: 38699204 PMC: 11063115. DOI: 10.1016/j.ncrna.2024.04.004.


Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.

Pan Y, Cengiz R, Kluiver J, Diepstra A, van den Berg A Cancers (Basel). 2024; 16(6).

PMID: 38539461 PMC: 10968648. DOI: 10.3390/cancers16061126.


Molecular micromanagement: DNA nanotechnology establishes spatio-temporal control for precision medicine.

Kimna C, Lieleg O Biophys Rev (Melville). 2024; 1(1):011305.

PMID: 38505628 PMC: 10903406. DOI: 10.1063/5.0033378.